.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Dow
US Department of Justice
Colorcon
Johnson and Johnson
Argus Health
Chinese Patent Office
Novartis
Medtronic
UBS

Generated: June 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022055

« Back to Dashboard
NDA 022055 describes ALTABAX, which is a drug marketed by Aqua Pharms Llc and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug. Additional details are available on the ALTABAX profile page.

The generic ingredient in ALTABAX is retapamulin. Three suppliers are listed for this compound. Additional details are available on the retapamulin profile page.

Summary for NDA: 022055

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antibacterials

Pharmacology for NDA: 022055

Ingredient-typepleuromutilin

Suppliers and Packaging for NDA: 022055

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALTABAX
retapamulin
OINTMENT;TOPICAL 022055 NDA Aqua Pharmaceuticals 16110-518 16110-518-15 1 TUBE in 1 CARTON (16110-518-15) > 15 OINTMENT in 1 TUBE
ALTABAX
retapamulin
OINTMENT;TOPICAL 022055 NDA Aqua Pharmaceuticals 16110-518 16110-518-30 1 TUBE in 1 CARTON (16110-518-30) > 30 OINTMENT in 1 TUBE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength1%
Approval Date:Apr 12, 2007TE:RLD:Yes
Patent:7,875,630Patent Expiration:Feb 14, 2027Product Flag?Substance Flag?YDelist Request?
Patent:8,207,191Patent Expiration:Aug 30, 2024Product Flag?Substance Flag?Delist Request?
Patented Use:TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES
Patent:RE43390Patent Expiration:Apr 12, 2021Product Flag?YSubstance Flag?YDelist Request?
Patented Use:TREATMENT OF IMPETIGO DUE TO STAPHYLOCOCCUS AUREUS OR STREPTOCOCCUS PYOGENES


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Moodys
Johnson and Johnson
Accenture
Federal Trade Commission
Cerilliant
Medtronic
Daiichi Sankyo
Healthtrust
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot